Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $693.70 | 12 | 86.2% |
| Education | $111.49 | 1 | 13.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $427.26 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $259.94 | 5 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $117.99 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $694.19 | 12 | Teva Pharmaceuticals USA, Inc. ($427.26) |
| 2023 | $111.00 | 1 | Neurocrine Biosciences, Inc. ($111.00) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $117.99 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Neuropsychiatry | ||||||
| 07/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Central Nervous System | ||||||
| 06/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Central Nervous System | ||||||
| 04/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Central Nervous System | ||||||
| 02/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $44.91 | General |
| Category: Neurology | ||||||
| 06/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $111.00 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 316 | 2,599 | $449,045 | $131,008 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 115 | 1,782 | $320,760 | $85,964 | 26.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 107 | 506 | $91,080 | $34,789 | 38.2% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 67 | 253 | $27,577 | $7,377 | 26.8% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 27 | 58 | $9,628 | $2,878 | 29.9% |
About Kerry Ramirez
Kerry Ramirez is a Psychiatric/Mental Health healthcare provider based in Universal City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2022. The National Provider Identifier (NPI) number assigned to this provider is 1568173136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kerry Ramirez has received a total of $805.19 in payments from pharmaceutical and medical device companies, with $694.19 received in 2024. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($693.70).
As a Medicare-enrolled provider, Ramirez has provided services to 316 Medicare beneficiaries, totaling 2,599 services with total Medicare billing of $131,008. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Universal City, TX
- Active Since 12/05/2022
- Last Updated 12/05/2022
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1568173136
Products in Payments
- Austedo XR (Drug) $270.86
- INGREZZA (Drug) $259.94
- NUPLAZID (Drug) $117.99
- UZEDY (Drug) $44.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.